Kessler, 2003 Jun 18, JAMA, 289, 3095, 10.1001/jama.289.23.3095
Janicak, 2009, Psychopharm Rev, 44, 41, 10.1097/01.IDT.0000350191.07142.ef
Mann, 2005, N Engl J Med, 353, 1819, 10.1056/NEJMra050730
Davidson, 2010, J Clin Psychiatry, 71, e04, 10.4088/JCP.9058se1c.04gry
Nelson, 2009 Sep, Am J Psychiatry, 166, 980, 10.1176/appi.ajp.2009.09030312
McIntyre, 2007 Jun, Expert Opin Pharmacother, 8, 1211, 10.1517/14656566.8.9.1211
Nyberg, 2010, Eur Psychiatry, 25, 1446, 10.1016/S0924-9338(10)71429-2
Jensen, 2008 Sep, Neuropsychopharmacol, 33, 2303, 10.1038/sj.npp.1301646
Nyberg, 2008, Eur Neuropsychopharmacol, 18, S270, 10.1016/S0924-977X(08)70352-3
Datto, 2009 Mar, Clin Ther, 31, 492, 10.1016/j.clinthera.2009.03.002
Mamo, 2008, J Clin Psychiatry, 69, 81, 10.4088/JCP.v69n0111
Gedge, 2010, Neuropsychiatric Dis Treat, 6, 501
De Vane, 2001, Clin Pharmacokinet, 40, 509, 10.2165/00003088-200140070-00003
Wang, 2006 Sep, Psychopharmacology, 187, 415, 10.1007/s00213-006-0437-9
Figueroa, 2009 Mar 17, Prog Neuropsychopharmacol Biol Psychiatry, 33, 199, 10.1016/j.pnpbp.2008.09.026
Bauer, 2009 Apr, J Clin Psychiatry, 70, 540, 10.4088/JCP.08m04629
El-Khalili, 2010, Int J Neuropsychopharmacol, 13, 917, 10.1017/S1461145710000015
Bauer, 2010 Dec, J Affect Disord, 127, 19, 10.1016/j.jad.2010.08.032
Bandelow, 2010, Int J Psychiat Clin Pract, 14, 19
Bauer, 2010, Int J Neuropsychopharmacol, 13, 143, 10.1017/S1461145709990186
